Skip to main content

Regeneron shares fall after judge blocks selling of cholesterol-lowering drug

US District Judge Sue Robinson in Delaware banned the marketing, selling or manufacturing of Regeneron's cholesterol-lowering drug Praluent.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.